Carolyn Myers

Carolyn J.
Myers is currently President, Chief Executive Officer & Director at FendX Technologies, Inc. since 2020.
Dr. Myers is also a Director at EyeD Pharma SA, Principal at Bio Ensemble Ltd., Committee Member and principal at Mid Atlantic Bio Angels LLC, and Principal at Bioensemble LLC since 2017.
Former roles include Global Director-Cardiovascular at Pharmacia, Inc., Non-Executive Director at Mayne Pharma Group Ltd. from 2021 to 2023, Independent Non-Executive Director at Hyloris Pharmaceuticals SA, Vice President at Mylan Laboratories, Inc. from 2003 to 2007, President at Mylan Specialty LP, President-Specialty Pharmaceutical Division at Mylan, Inc., President at Mylan Technologies, Inc. from 2006 to 2007, President at Dey Laboratories, Inc., Vice President-CNS Marketing at Forest Laboratories, Inc. from 2011 to 2013, and Vice President-Global Business Development at Allergan UC from 2011 to 2017.
Education includes an MBA from Rutgers State University of New Jersey and a doctorate from the University of British Columbia.